MRC Impact Accelerator Accounts (Previously Confidence in Concept)
The tropical Infectious Disease Consortium (TIDC) has been awarded £1.6 million from the Medical Research Council (MRC) via the Impact Acceleration Account (IAA), previously Confidence in Concept (CiC). The TIDC is a strategic partnership between Liverpool School of Tropical Medicine (LSTM), UK Health Security Agency, London school of Hygiene & Tropical Medicine (LSHTM), the University of Oxford and has been expanded for this call to include the Science and Technology Facilities Council (STFC) and the Pirbright Institute. The TIDC has been awarded £1.6million over 3 years and represents the largest award to date. The award will allow the Consortium to support pump-priming projects, typically in the range of £50K, with the overreaching ambition to accelerate the transition from discovery science into therapeutic, diagnostic and vaccine development.
In 2017 applications were invited for institutions to establish National Institute for Health Research (NIHR) Global Health Research Units and Groups, which can deliver measurable benefits to patients and the public in low and middle-income countries (LMICs).
Wellcome Trust Institutional Strategic Support Fund (ISSF) offers financial support to enhance institutional strategies for the biomedical sciences. They also provide incentives for institutions to support scientific progress, translation and interdisciplinary collaboration and to encourage greater efficiency, effectiveness and accountability in the stewardship of Wellcome Trust funding.